Which Undervalued Stocks Is This Investor Buying?

TL;DR

The investor is cautiously buying more Nebius, Alibaba, a Latin American e-commerce company, UnitedHealth, and Oscar Health while reserving cash for earnings-season opportunities. Nebius and Alibaba positions each increased by about 8%, while the small healthcare holdings support an “invest and investigate” strategy. Read on for the portfolio rationale, price considerations, and risks behind these purchases.

Transcript

Hey everyone and welcome back to another portfolio update for you today. So the couch investing portfolio was up 1.59% over the past week while the S&P was down. 28%. Year to date, as you can see, we're still up 21.53% whereas the market is up 6.41% and since the start of the portfolio, we are up 94% whereas the S&P 500 is up 25.54%. So, we're goin... Read More

Key Insights

• The portfolio remains concentrated in its largest holdings, even though it contains numerous smaller positions. SoFi is the leading position, while Google has moved ahead of PayPal, and the investor treats the remaining holdings as potential contributors rather than equal-weight commitments.
• The investor is keeping cash available because earnings season may create more attractive opportunities. Recent additions were deliberately measured, reflecting a preference to preserve flexibility before companies report results and potentially experience large price movements.
• Nebius is intended to become a larger part of the portfolio over time. The investor has already increased the position and would consider buying more if the share price declines further, especially toward the level specifically discussed in the transcript.
• Alibaba remains an active accumulation target because the investor considers the position attractive and is still profitable on it. The holding also generated dividend income, which the investor cites as tangible cash rather than merely an unrealized portfolio gain.
• UnitedHealth and Oscar Health are small research positions built through an invest-and-investigate approach. The investor gains financial exposure first, then studies each business while retaining time to add gradually as earnings, management commentary, and operating performance provide more evidence.
• Oscar Health is viewed as a possible long-term multibagger, but conviction is deliberately limited by incomplete industry understanding. The investor therefore keeps the position much smaller than major holdings such as Google or PayPal and emphasizes management quality before committing substantially more capital.
• Oscar Health management expects the business to progress from its first profitable period toward stronger margins and higher revenue. The investor finds the operating targets compelling, while recognizing that management projections still require continued execution and should not be treated as guaranteed outcomes.
• Tesla remains in the investor's separate core portfolio rather than the public portfolio because additional exposure was considered unnecessary. The investor continues tracking Tesla's China activity, in-car AI integration, Indian market entry, and leading positions among bestselling electric vehicles in the United States.

Questions & Answers

Q: Which undervalued stocks is the investor buying?

The investor added to Nebius, Alibaba, a Latin American e-commerce company, UnitedHealth, and Oscar Health. The purchases were deliberately measured because earnings season could create better opportunities, and the UnitedHealth and Oscar Health positions remain small while further research continues.

Q: How much did the investor add to Nebius and Alibaba?

The Nebius position increased by 8%, and the investor would consider buying more if its share price falls toward $40. The Alibaba position increased by 8.33%, and the investor also received $126 in Alibaba dividends.

Q: Why is the investor keeping cash during earnings season?

The investor expects upcoming earnings reports to create large stock-price movements and potentially better buying opportunities. Keeping some cash available provides flexibility to add when results or management commentary strengthen an investment case or cause an attractive decline.

Q: What does “invest and investigate” mean for UnitedHealth and Oscar Health?

It means opening a small position and then researching the company more deeply while holding it. The investor is using this approach with UnitedHealth and Oscar Health, allowing time to evaluate their businesses and management before committing substantially more money.

Q: Why does the investor want Nebius to become a larger holding?

The investor wants Nebius to represent a bigger portion of the overall portfolio and has already increased the position by 8%. If the stock continues falling toward approximately $40, the investor plans to consider adding more.

Q: Why is the investor interested in Oscar Health?

Oscar Health is viewed as a speculative potential multibagger because of its smaller size and management’s expectations for improving margins and revenue. However, the investor does not claim to understand the industry completely, so the position remains small and will never be as large as Google or PayPal.

Q: What is the investor’s outlook for UnitedHealth?

UnitedHealth is a small position representing 1.5% of the portfolio, or about $4,000. The investor expects a significant move around its July 29 quarterly report and considers a possible 50% increase, equal to roughly $2,000 in gains, an attractive outcome over six months.

Q: How concentrated is the investor’s portfolio?

SoFi remains the largest holding by far, with Google moving into second place ahead of PayPal. Although the portfolio contains numerous companies, smaller holdings such as UnitedHealth and Oscar Health do not carry the same position size or conviction as its established leaders.

Summary & Key Takeaways

• The portfolio outperformed the broader market over the periods presented, with SoFi remaining its largest holding and Google moving ahead of PayPal. Rocket Lab, Micron, Uber, and AMD performed well, while Intel approached profitability. The investor still expects volatility and would welcome selected pullbacks as opportunities to accumulate shares.

• Recent purchases increased positions in Nebius, Alibaba, a Latin American e-commerce company, UnitedHealth, and Oscar Health. The investor is preserving cash because earnings season could produce better entry points. Smaller healthcare allocations reflect an invest-and-investigate strategy, allowing exposure while additional research determines whether larger commitments are justified.

• Oscar Health is viewed as a speculative potential multibagger because management expects improving margins and revenue, but the investor acknowledges limited industry knowledge. Tesla remains in a separate core portfolio, while its China insurance registrations, in-car AI integration, planned Indian expansion, and strong United States electric-vehicle rankings remain under observation.